Leading Sites

Category

Salt Lake City’s Foothill Family Clinic Rapidly Enrolls Vaccine Participants for Two Phase 3 Clinical Trials

Thanks to a partnership with J Lewis Research, healthcare provider Foothill Family Clinic in Salt Lake City, Utah, is conducting two Phase 3 clinical trials for COVID-19 vaccine candidates from both Moderna (mRNA-1273) and Pfizer (BioNTech’s BNT 162). The...

New NIH Investigator Network: NIAID Commits $82m to Form Center for Research in Emerging Diseases (CREID)

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, today announced that it has awarded 11 grants with a total first-year value of approximately $17 million to establish the Centers for Research in Emerging...

University of Illinois Chicago Gears up to Recruit up to 1,000 Diverse Participants for the COVID-19 Vaccine Trial Involving mRNA-1273

The University of Illinois’ Health System launches the COVID-19 vaccine trial testing Moderna’s mRNA-1273 starting this Monday. Led by University of Illinois Chicago, the center targets enrollment of up to 1,000 participants for this clinical trial. Led by Dr. Richard...

Masonic Medical Research Institute Investigating the Connections of COVID-19 to Cardiovascular Conditions

Masonic Medical Research Institute in Utica, New York, now investigates the cardiovascular implications of COVID-19. Led by Dr. Nathan Tucker, Assistant Professor, the research operation sought to better understand why at least some patients infected with SARS-CoV-2,...

Independent Aventiv Research Selected by Pfizer & BioNTech for COVID-19 Vaccine Trial: Volunteers Drive 2 Hours to Contribute

Independently-owned Columbus Ohio-based Aventiv Research was selected by the Pfizer/BioNTech “Project Lightspeed” program to participate in the Phase 2/3 clincial trial to test the RNA-based COVID-19 vaccine. With involvement of 120 sites around the world, this...

Kaiser Permanente Targets 5% of Worldwide Volunteer Enrollment for Project Lightspeed COVID-19 Vaccine Trial

Ranked as the 18th largest healthcare system in the United States, Kaiser Permanente isn’t afraid of ambitious targets as its’ California-based research organizations are no exception, raising the bar by planning to enroll up to 5% of all study participants...

UC Davis Health Ramps Up Project Lightspeed: Serves as Trial Site for Phase 2/3 BNT162 COVID-19 Vaccine Study

UC Davis Health was one of about 120 trial sites selected worldwide to participate in the Phase 2/3 stage testing of the COVID-19 vaccine candidate known as BTN162, developed by Germany’s BioNTech and Pfizer Inc. The addition of this pivotal clinical trial adds even a...

Seres Therapeutics Reports Positive Phase III Data from ECOSPOR III Trial of its Oral Microbiome Therapy SER-109 for Recurrent C. Difficile Infection

Seres Therapeutics reported positive topline results from the pivotal Phase 3 ECOSPOR III study evaluating its investigational oral microbiome therapeutic SER-109 for recurrent C. difficile infection (CDI). The primary endpoint was reached, with SER-109...

MedPharmics Selected by AstraZeneca for Phase 3 COVID-19 Vaccine Trial: First Site in New Mexico to Enroll Soon

MedPharmics LLC, based in Louisiana, has mobilized its Albuquerque, New Mexico trial site location to support a COVID-19 vaccine clinical trial sponsored by AstraZeneca and Oxford University. In fact, this will be the first such site in all of New Mexico to enroll...

Northwestern Medicine Launches Major COVID-19 Study Registry & Gears up for AZD1222 Clinical Trial

Northwestern Medicine has been selected by AstraZeneca for participation in the prominent AZD1222 Phase 3 COVID-19 vaccine trial. One of the most promising of vaccine candidates it was originally developed by University of Oxford.  Northwestern University, one of...

Wake Forest Baptist Health & Javara Research as a Care Option Partnership Put to the Test on the mRNA-1273 COVID-19 Vaccine Trial

By September 2018, Javara and Wake Forest Baptist Health announced their intention to deliver the clinical research as a care option to the patients of this region. Fast forward nearly two years, and the partnership now embraces a major test: it must produce results...

Pin It on Pinterest